Flowers Lee 4
4 · HCW Biologics Inc. · Filed Jun 9, 2023
Insider Transaction Report
Form 4
Flowers Lee
SVP of Business Development
Transactions
- Exercise/Conversion
Common Stock
2023-06-08$0.14/sh+5,356$750→ 101,308 total - Purchase
Common Stock
2023-06-08$2.16/sh+10,000$21,574→ 111,308 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-06-08−5,356→ 7,501 totalExercise: $0.14Exp: 2029-09-18→ Common Stock (5,356 underlying)
Footnotes (1)
- [F1]20% of the total shares subject to the stock option grant vested on September 16, 2020; 20% of the total shares subject to the stock option grant vested on September 16, 2021; 25% of the total shares subject to the stock option grant will vest on September 16, 2022; and 35% of the total shares subject to the stock option grant will vest on September 16, 2023.